Tadalafil 20mg Research Overview
Tadalafil 20mg is a selective phosphodiesterase type 5 (PDE-5) inhibitor manufactured by Aurochem Pharmaceuticals for laboratory research applications. This compound demonstrates potent and selective inhibition of the PDE-5 enzyme, which plays a crucial role in cyclic guanosine monophosphate (cGMP) degradation within vascular smooth muscle cells. Researchers investigating cardiovascular mechanisms, vascular biology, and nitric oxide signalling pathways utilise tadalafil in controlled laboratory environments to examine its biochemical properties and molecular interactions. The 20mg tablet formulation provides consistent dosing for quantitative research protocols examining PDE-5 inhibition kinetics and downstream signalling cascades.
Laboratory Applications
Research scientists employ tadalafil in various in-vitro studies to investigate vascular smooth muscle relaxation mechanisms and endothelial function. The compound’s selectivity for PDE-5 over other phosphodiesterase isoforms makes it valuable for examining specific cyclic nucleotide pathways without significant cross-reactivity. Laboratory protocols often examine tadalafil’s effects on intracellular cGMP levels, calcium mobilisation, and vascular tone regulation in isolated tissue preparations. Cardiovascular research facilities analyse this compound’s pharmacokinetic properties, including its extended half-life characteristics and tissue distribution patterns. Molecular biology laboratories study tadalafil’s binding affinity to PDE-5 active sites and its competitive inhibition mechanisms. Our Stroid UK Shop maintains rigorous quality standards for all laboratory compounds. Researchers also investigate potential therapeutic applications in various disease models, examining the compound’s effects on pulmonary arterial pressure and systemic vascular resistance. The erection drugs category contains additional PDE-5 inhibitors for comparative studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tadalafil |
| Strength | 20mg per tablet |
| Manufacturer | Aurochem Pharmaceuticals |
| CAS Number | 171596-29-5 |
| Molecular Formula | C₂₂H₁₉N₃O₄ |
| Molecular Weight | 389.40 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Classification | PDE-5 inhibitor |
Laboratory storage protocols recommend maintaining tadalafil tablets in controlled temperature conditions below 25°C with protection from moisture and direct sunlight. Research facilities studying comparative pharmacology often examine tadalafil alongside other research compounds available through our SARMs collection and peptides research section for comprehensive molecular studies.
Research Compliance
This tadalafil 20mg product is manufactured by Aurochem Pharmaceuticals exclusively for in-vitro research purposes and laboratory studies. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with institutional guidelines and local regulations when handling PDE-5 inhibitor compounds in laboratory settings.
